Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,953 | 450 | 98.8% |
| Education | $84.23 | 8 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,119 | 72 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $864.83 | 39 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $668.71 | 35 | $0 (2020) |
| PFIZER INC. | $645.31 | 71 | $0 (2020) |
| Novo Nordisk Inc | $639.18 | 34 | $0 (2020) |
| Amgen Inc. | $489.54 | 26 | $0 (2019) |
| Lilly USA, LLC | $385.39 | 25 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $349.74 | 18 | $0 (2020) |
| Merck Sharp & Dohme LLC | $334.45 | 39 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $231.05 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.42 | 1 | Dexcom, Inc. ($20.42) |
| 2022 | $21.70 | 1 | Merck Sharp & Dohme LLC ($21.70) |
| 2020 | $363.12 | 22 | AstraZeneca Pharmaceuticals LP ($58.06) |
| 2019 | $2,176 | 132 | Janssen Pharmaceuticals, Inc ($401.48) |
| 2018 | $2,330 | 148 | Janssen Pharmaceuticals, Inc ($368.41) |
| 2017 | $2,126 | 154 | AstraZeneca Pharmaceuticals LP ($350.75) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Endocrinology | ||||||
| 06/16/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/10/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Endocrinology | ||||||
| 03/09/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 03/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
| 03/03/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DIABETES | ||||||
| 02/20/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/11/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Endocrinology | ||||||
| 02/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/05/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Oncology | ||||||
| 02/05/2020 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 02/04/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Neuroscience | ||||||
| 01/31/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: VACCINES | ||||||
| 01/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: DIABETES | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/22/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/15/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardiovascular | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 01/08/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Central Nervous System | ||||||
| 12/29/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Durable Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 635 | 912 | $145,415 | $60,578 |
| 2022 | 11 | 673 | 946 | $150,186 | $63,864 |
| 2021 | 10 | 1,013 | 1,262 | $169,501 | $76,222 |
| 2020 | 12 | 766 | 1,092 | $169,296 | $63,291 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 337 | $75,488 | $27,985 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $20,898 | $11,290 | 54.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 91 | 92 | $16,192 | $7,095 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 96 | $14,496 | $5,349 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $6,020 | $2,717 | 45.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 44 | 44 | $2,640 | $1,757 | 66.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 56 | $2,968 | $1,757 | 59.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 24 | 30 | $2,460 | $1,217 | 49.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 78 | 99 | $3,564 | $1,004 | 28.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $689.00 | $407.81 | 59.2% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 39 | 39 | $0.39 | $0.37 | 94.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 298 | $66,752 | $23,723 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $22,356 | $12,405 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 187 | $28,237 | $12,101 | 42.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 93 | 94 | $16,544 | $7,650 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 70 | 73 | $3,869 | $2,238 | 57.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,311 | $1,555 | 47.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 80 | 105 | $3,780 | $1,022 | 27.0% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 26 | 26 | $1,560 | $971.04 | 62.2% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 19 | 19 | $1,140 | $774.20 | 67.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $1,325 | $771.76 | 58.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 16 | 16 | $1,312 | $652.15 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 313 | $70,112 | $24,109 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 117 | 117 | $28,431 | $16,139 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 121 | $18,271 | $8,715 | 47.7% |
About Dr. Hugo Yamada, MD
Dr. Hugo Yamada, MD is a Internal Medicine healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932196904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hugo Yamada, MD has received a total of $7,037 in payments from pharmaceutical and medical device companies, with $20.42 received in 2023. These payments were reported across 458 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,953).
As a Medicare-enrolled provider, Yamada has provided services to 3,087 Medicare beneficiaries, totaling 4,212 services with total Medicare billing of $263,956. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lincoln, RI
- Active Since 10/04/2005
- Last Updated 07/25/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932196904
Products in Payments
- XARELTO (Drug) $840.94
- FARXIGA (Drug) $558.95
- JARDIANCE (Drug) $433.97
- CHANTIX (Drug) $342.50
- JANUVIA (Drug) $312.75
- SYMBICORT (Drug) $288.39
- ELIQUIS (Drug) $279.97
- INVOKANA (Drug) $278.16
- Victoza (Drug) $267.57
- TRADJENTA (Drug) $217.22
- Prolia (Biological) $201.01
- TRULICITY (Drug) $185.33
- TOUJEO (Drug) $181.67
- Ozempic (Drug) $169.30
- PREVNAR - 13 (Biological) $136.71
- Tresiba (Drug) $131.23
- EMGALITY (Drug) $121.78
- ENTRESTO (Drug) $110.51
- Aimovig (Biological) $103.10
- VIAGRA (Drug) $95.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lincoln
Brock Cookman, D.o, D.O
Internal Medicine — Payments: $694,509
Dr. Ryan Martin, Md, MD
Internal Medicine — Payments: $414,185
Matthew Johnson, M.d, M.D
Internal Medicine — Payments: $307,471
Dr. Sherri Thomas, Do, DO
Internal Medicine — Payments: $100,336
Frank D'alessandro, Md Inc, MD INC
Internal Medicine — Payments: $86,860
Peter Gallagher, M.d, M.D
Internal Medicine — Payments: $83,162